Booth Fees, Assignment Procedures & Cancellation Information

Purpose of Exhibits
ATC is sponsored by ASTS and AST, both non-profit, tax-exempt, scientific and educational associations. The purpose of the exhibits, an integral part of the Congress’s educational activity, is to complement the scientific and clinical sessions by enabling attendees to evaluate the latest developments in products presented for use by transplant physicians and surgeons. Each exhibitor is responsible for making sure that all attending personnel are aware of these provisions.

Exhibit/Exhibitor Eligibility
Exhibits at the American Transplant Congress (“ATC” or “the Congress”) are designed for the display and demonstration of products and/or services directly related to the practice and advancement of the science of transplantation. All products and services exhibited must be germane to the study and practice of transplantation and have appropriate governmental and agency approval, if such is required. ATC retains the sole authority to determine the eligibility of any exhibitor and/or its product. ATC reserves the right to refuse applications of organizations not meeting standard requirements or expectations. ATC reserves the right to curtail or to close exhibits, wholly or in part, that reflects unfavorably on the character and the purpose of the Congress, whether due to displays, literature, advertising novelties, souvenirs, conduct of persons or otherwise.

Booth Prices
Booth Size: 10’ x 10’
In-Line Booth: $2,835.00
Corner Booth: $2,940.00
Island Rate:* $33.00 per square foot
(20’ x 20’ = $13,200.00)
Tax-Exempt: $550 - Proof of tax-exempt status must accompany completed application.

Terms of Payment
Total booth fee is due with completed exhibit application. Payments may be made online by going to www.2012.atcmeeting.org or should be made by completing the application contract on page 16 of this prospectus. Payments may be mailed or faxed to the American Transplant Congress, Attention: Robin Geary, CMP, 15000 Commerce Parkway, Suite C, Mt. Laurel, NJ 08054-2212. All checks should be made payable to ASTS/AST. Space will not be assigned or held without the completed application and full payment.

Assignment of Space
Exhibit space assignments will be made on a first-come, first-served basis, provided that Congress management shall take into consideration both exhibitor requests and space configurations necessary for the Congress. Management reserves the right to make any revisions necessary to the floor plan at any time. ATC reserves the right to relocate an exhibitor at any time with the understanding that, if the exhibitor does not agree to such relocation and determines that it cannot participate in ATC, the deposit and/or full payment for exhibit space will be fully refunded. Exhibitors wishing to avoid assignment of space adjacent to that of a particular competitor must note that on their application. Although consideration will be given to all such requests, approving such requests cannot be absolutely guaranteed.
Designated Tax-Exempt Organization Area Exhibitors which qualify as organizations exempt from U.S. federal income taxation or its foreign equivalent are eligible to receive a reduced booth fee for a maximum of one 10’ x 10’ booth. Proof of taxexempt status must accompany the completed application. Tax-exempt organization space assignments will be confined to a specific area on the floor plan. Tax-exempt exhibitors do not have the option to choose booth space in other locations on the exhibit floor at the reduced rate. The taxexempt organization booth fee includes: one 10’ x 10’ booth space, side and back drape, and one I.D. sign. Additional booths will be charged the regular booth fee. Tax-exempt exhibitors are required to provide carpeting and accessories for their booth space. If exhibit space is unavailable in the tax-exempt organization area, space will not be available elsewhere unless the tax-exempt organization pays the regular booth fee.

Cancellation or Downsizing of Booth Space
Cancellations or requests to downsize must be submitted to the ATC Exhibit Manager in writing. If written notice of cancellation is received in the ATC headquarters office on or before March 1, 2012, ATC shall retain as liquidated damages 25% of the total booth fee. If written notice of cancellation is received by ATC after March 1, 2012, ATC shall retain as liquidated damages the entire booth fee. If written notification of downsizing booth space is received on or before March 1, 2012, the exhibitor is responsible for 25% of the original exhibit space fee, plus the cost of the redefined exhibit space. No decreases in booth size or configuration may be made after March 1, 2012.

The parties acknowledge and agree that ATC will sustain certain losses if an exhibiting company attempts to cancel or downsize its exhibit space after entering into an exhibit space contract. Because it would be difficult if not impossible to quantify these damages, the parties agree that this provision for liquidated damages is necessary and appropriate. In the event that the exhibitor fails to pay the full exhibit booth fee by the date specified in the body of the contract, ATC reserves the right to consider said failure to be a cancellation of the exhibit space, to lease said space to another exhibitor and to retain any deposit as liquidated damages.

Failure to Occupy Space
Booth space not occupied by the exhibitor by 2:00 pm on Saturday, June 2, 2012, is forfeited without refund to the exhibitor, and the space may be resold or used by ATC.

Cancellation of Exposition
It is mutually agreed that in the event of cancellation of the American Transplant Congress due to fire, strikes, governmental regulations, war, acts of God, terrorism or other causes which would prevent its scheduled opening or continuance, then and thereupon this contract will be terminated and the American Transplant Joint Council shall determine an equitable basis for the refund of such portion of the exhibit fees as is possible, after due consideration of previous expenditures and commitments.

Food and Drug Administration (FDA) Market Clearance
All products exhibited must have fulfilled all applicable FDA regulations. Products that are not FDA-approved for a particular use in humans or are not commercially available in the United States will be permitted to be displayed only when accompanied by appropriate signs that indicate FDA clearance status. The signs must be clearly and easily visible and placed near the product and on any graphics depicting the product. Display of investigational products is permitted only within the limitations of the Food and Drug Administration’s Guidelines on Notices of Availability. Any investigational product graphically depicted on a commercial exhibit
should:

• Contain only objective statements about the product.
• Contain no claims of safety, effectiveness, or reliability.
• Contain no comparative claims to other marketed products.
• Exist solely for the purpose of obtaining investigators.
• Be accompanied by directions for becoming an investigator and list of investigator responsibilities.
• Contain a statement on signage: “Caution-Investigational Product- Limited to Investigational Use” (or similar statement) in prominent size and placement.

It is the exhibitor’s responsibility to contact the FDA to ensure compliance with the current FDA guidelines. Exhibitors must contact the FDA Office of Compliance regarding responsibilities under the Federal Food Drug & Cosmetic Act.